DIVIDEND ANNOUNCEMENT: Johnson & Johnson (NYSE:JNJ) on 01/02/2026 declared a dividend of $1.3000 per share

Johnson & Johnson (NYSE:JNJ) on 01/02/2026 declared a dividend of $ 1.3000 per share payable on March 10, 2026 to shareholders of record as of February 24, 2026.

Johnson & Johnson (NYSE:JNJ) has paid dividends since 1944, has a current dividend yield of 2.5126841068% and has increased its dividends for 63 successive years.

Johnson & Johnson's market cap is $ 498,603,600,250 and has a PE ratio of 19.98. The stock price closed yesterday at $ 206.95 and has a 52 week low/high of $ 140.68 and $ 215.18.

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Co.'s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

For more information on Johnson & Johnson click here.